Literature DB >> 2230242

Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.

S V Hetherington1, A F Rutkowski.   

Abstract

The affinities of IgG antibodies to Haemophilus influenzae b capsular polysaccharide (polyribosyl ribitol phosphate [PRP]) elicited 1 month after immunization of 47 infants 2-greater than 18 months of age with a PRP-outer membrane protein conjugate (PRP-OMP) were measured by ELISA. Thirty-four sera had affinities distributed normally about a logarithmic mean of 3.2 x 10(5) l/mol, but 13 samples had undetectable affinities (less than 10(4) l/mol). Median affinities of sera from children 2-6 (1.5 x 10(5) l/mol) and 7-11 months of age (1.6 x 10(5) l/mol) were significantly greater than the median affinities of sera from infants 12-18 (1.8 x 10(4) l/mol) or greater than 18 months of age (4.2 x 10(4) l/mol). Sera from children greater than 18 months of age vaccinated with PRP conjugated to diphtheria toxoid had a median affinity of 6.1 x 10(4) l/mol, equivalent to that of the same age group vaccinated with PRP-OMP. Children vaccinated with PRP conjugate vaccines may produce antibodies of very low affinity, a finding that may have significance for protection from invasive disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230242     DOI: 10.1093/infdis/162.5.1185

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.

Authors:  Sandra Romero-Steiner; Patricia F Holder; Patricia Gomez de Leon; Willie Spear; Thomas W Hennessy; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b.

Authors:  A E Agbarakwe; H Griffiths; N Begg; H M Chapel
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

4.  Evaluation of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) in Canadian infants.

Authors:  D W Scheifele; G L Bjornson; W G Meekison; R Guasparini; L A Mitchell
Journal:  Can J Infect Dis       Date:  1994-03

5.  Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.

Authors:  Y Sun; Y i Hwang; M H Nahm
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Reduced expression of the interleukin-2-receptor gamma chain on cord blood lymphocytes: relationship to functional immaturity of the neonatal immune response.

Authors:  H Zola; M Fusco; H Weedon; P J Macardle; J Ridings; D M Roberton
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

Review 7.  B-cell responses to vaccination at the extremes of age.

Authors:  Claire-Anne Siegrist; Richard Aspinall
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

8.  Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2.

Authors:  P Chong; Y P Yang; R Fahim; P McVerry; C Sia; M Klein
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.